Search results for "Breakthrough"

showing 5 items of 55 documents

Treatment strategies for cancer patients with breakthrough pain.

2009

Breakthrough pain (BTP) is a transitory flare of pain superimposed on an otherwise stable pain pattern in patients treated with opioids. It is normally severe in intensity, has a rapid onset, has a variable duration (on average 30 min) and is considered a negative prognostic factor. OBJECTIVE: To verify the data in the literature about therapy strategies for BTP in cancer patients. METHODS: To find clinical trials investigating drug therapy for BTP. CONCLUSION: The treatment of BTP in cancer patients receiving opioids is principally based on the use of opioids, preferentially with a short onset. Fentanyl delivered by recently developed systems seems to be the best option to cover the tempor…

medicine.medical_specialtySettore MED/06 - Oncologia MedicaBreakthrough PainPainFentanylPharmacotherapyNeoplasmsInternal medicinemedicineAnimalsHumansPharmacology (medical)In patientPain MeasurementPharmacologybusiness.industryCancerGeneral Medicinemedicine.diseaseAnalgesics OpioidFentanylClinical trialTreatment OutcomeAnesthesiaTreatment strategycancer pain opiods breakthrough painbusinessCancer painmedicine.drug
researchProduct

Breakthrough pain in cancer patients

2015

The aim of this article was to examine the definition, the characteristics, and the management of breakthrough cancer pain (BTP) in cancer patients by a critical review of recent literature.BTP should be more correctly defined as an episode of severe intensity in patients receiving an adequate treatment with opioids able to provide at least mild analgesia. BTP is a heterogeneous condition as episodes vary between individuals. BTP can be classified into two big distinct pictures: spontaneous-type and incident-type pain. The principal pharmacological treatment of BTP is represented by the administration of opioids as needed. Recent reviews revealed that transmucosal preparation of fentanyl pr…

medicine.medical_specialtybusiness.industryBreakthrough PainBreakthrough PainMEDLINETreatment optionsCancermedicine.diseasePain IntractableAnesthesiology and Pain MedicineNeoplasmsPrevalencemedicinePhysical therapyHumansIntensive care medicinebusinessCancer painCurrent Opinion in Anaesthesiology
researchProduct

Dissatisfaction with post-operative pain management—A prospective analysis of 1071 patients

2005

Summary A total number of 1071 patients was investigated using a modified questionnaire of the American Pain Society to evaluate the pain profile and satisfaction/dissatisfaction on the second post-operative day after different types of surgery (abdominal, traumatic, orthopaedic, urologic, gynaecologic, ENT). Patients were either treated with non-standardized pain management (no measurement of pain intensities, no regular administration of analgesics) (non-APS; n = 575) under responsibility of surgical specialties or with standardized pain management (regular assessment of pain and dose adaptation with i.v. PCA or epidurals) (APS; n = 496) by an anaesthesiology-based acute pain service. Pat…

medicine.medical_specialtybusiness.industryBreakthrough Painmedia_common.quotation_subjectAnalgesicPain managementProspective analysisAnesthesiology and Pain MedicineFeelingEmergency MedicinePhysical therapymedicinePain catastrophizingProspective cohort studybusinessPost operative painmedia_commonAcute Pain
researchProduct

Breakthrough Cancer Pain: Ten Commandments

2016

The term "breakthrough cancer pain" (BTcP) was introduced about 25 years ago. Peaks of pain intensity reported in patients with cancer had been invariably examined in the past years, providing relevant information for a better knowledge of this phenomenon and its treatment. The aim of this critical review was to provide the golden rules, namely, the 10 commandments, for a correct diagnostic pathway of BTcP and a consequent personalized pharmacological treatment. These are as follows: 1) assessment of background analgesia, 2) drugs used for background analgesia, 3) BTcP is a frequent phenomenon, 4) characteristics of BTcP, 5) diagnosis of BTcP, 6) continuous assessment, 7) tailored pharmacol…

medicine.medical_specialtybusiness.industryHealth PolicyBreakthrough PainPublic Health Environmental and Occupational HealthAlternative medicineCancer PainPharmacological treatment03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisAnesthesiaHumansPain ManagementMedicineIn patientDosingbusinessCancer painIntensive care medicineRelevant information030217 neurology & neurosurgeryValue in Health
researchProduct

Column Adsorption Studies for the Removal of Ammonium Using Na-Zeolite-Based Geopolymers

2022

The aim of this study was to examine the removal of ammonium ions from a synthetic model solution by using Na-zeolite-based geopolymers. Na-zeolite (=analcime) is a residue from mining industry. Three adsorbents were prepared from Na-zeolite using different production steps and metakaolin as a blending agent. These novel adsorbents were investigated in a fixed-bed column system where the effects of different flow rates with the initial ammonium concentration of 40 mg/L were studied. The Thomas, Bohart–Adams and Yoon–Nelson breakthrough curve models fitted well with the experimental data with a high R2 value. After adsorption experiments, adsorbents were regenerated using a mixture of 0.2 M …

regenerationgeopolymeeritammonium ionfixed-bed columngeopolymerbreakthrough models
researchProduct